Lipitor's Average Cholesterol Reduction
Lipitor (atorvastatin) lowers LDL cholesterol by a mean of 35-60% at standard doses (10-80 mg daily), depending on dose, patient baseline, and study population. In pivotal trials like CURVES, 20 mg reduced LDL by 46% on average, while 80 mg achieved about 57%.[1][2]
How Reductions Vary by Dose
- 10 mg: ~39% LDL drop
- 20 mg: ~46%
- 40 mg: ~51%
- 80 mg: ~57%
These come from dose-response data in hypercholesterolemic patients over 6-18 weeks. Total cholesterol falls 25-45%, triglycerides 20-40%, and HDL rises 5-9%.[1][3]
Factors Affecting the Mean Decrease
Baseline LDL (higher yields bigger drops), age, diet, and comorbidities influence results. In diabetics or those with heart disease, like in the TNT trial, 80 mg cut LDL by 56% vs. 29% on 10 mg, reducing cardiac events.[2][4] Women and elderly patients often see similar or slightly higher reductions.
Time to Peak Effect
Maximal lowering hits by 2-4 weeks; full benefits stabilize at 4-6 weeks. No further drop beyond that without dose hikes.[1]
Compared to Other Statins
Lipitor outperforms simvastatin (40% at 40 mg) and pravastatin (30% at 40 mg) on LDL reduction per dose. Rosuvastatin matches or edges it at high doses (55-60%).[3][5]
Patent and Generic Availability
Lipitor's key composition patent expired in 2011; generics (e.g., atorvastatin from Teva, Mylan) match branded efficacy at lower cost. No active exclusivity blocks U.S. sales.[6]
[1]: FDA Label for Lipitor
[2]: NEJM: TNT Trial
[3]: Lancet: CURVES Study
[4]: JAMA: ASCOT-LLA
[5]: DrugPatentWatch: Atorvastatin Patents
[6]: FDA Orange Book: Atorvastatin